Published in Blood on May 15, 1998
Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med (2008) 5.82
Telomere diseases. N Engl J Med (2009) 5.68
Current concepts in the pathophysiology and treatment of aplastic anemia. Blood (2006) 5.20
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood (2007) 3.86
T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06
Dyskeratosis congenita. Hematol Oncol Clin North Am (2009) 2.45
Human diseases of telomerase dysfunction: insights into tissue aging. Nucleic Acids Res (2007) 2.34
Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA. Proc Natl Acad Sci U S A (2003) 2.18
Aplastic anemia. Curr Opin Hematol (2008) 2.17
Telomere maintenance and human bone marrow failure. Blood (2008) 2.09
Exonuclease-1 deletion impairs DNA damage signaling and prolongs lifespan of telomere-dysfunctional mice. Cell (2007) 1.96
The Shwachman-Diamond SBDS protein localizes to the nucleolus. Blood (2005) 1.95
The genetics and clinical manifestations of telomere biology disorders. Genet Med (2010) 1.83
Fanconi anaemia. J Med Genet (2003) 1.70
Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J (2003) 1.64
Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes. Aging (Albany NY) (2010) 1.62
The role of telomere biology in bone marrow failure and other disorders. Mech Ageing Dev (2007) 1.56
The genetics of dyskeratosis congenita. Cancer Genet (2011) 1.50
Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma. J Clin Oncol (2009) 1.29
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation. Br J Cancer (2001) 1.28
Bone marrow failure and the telomeropathies. Blood (2014) 1.23
Fanconi anemia proteins and endogenous stresses. Mutat Res (2009) 1.11
Contributions of DNA interstrand cross-links to aging of cells and organisms. Nucleic Acids Res (2007) 1.09
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy. Transl Res (2013) 1.08
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria. BMC Blood Disord (2004) 1.05
Learning from a paradox: recent insights into Fanconi anaemia through studying mouse models. Dis Model Mech (2013) 1.05
YNMG tetraloop formation by a dyskeratosis congenita mutation in human telomerase RNA. RNA (2003) 1.00
Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms. Leukemia (2008) 1.00
Regulation of senescence in cancer and aging. J Aging Res (2011) 0.98
Aging stem cells, latexin, and longevity. Exp Cell Res (2008) 0.94
Exome sequencing identifies MPL as a causative gene in familial aplastic anemia. Haematologica (2011) 0.93
Identification and functional characterization of novel telomerase variant alleles in Japanese patients with bone-marrow failure syndromes. Blood Cells Mol Dis (2007) 0.92
Predicting 5-fluorouracil toxicity in colorectal cancer patients from peripheral blood cell telomere length: a multivariate analysis. Br J Cancer (2012) 0.92
Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies. Curr Pharmacogenomics Person Med (2010) 0.87
Telomere-regulating genes and the telomere interactome in familial cancers. Mol Cancer Res (2014) 0.87
FANCC suppresses short telomere-initiated telomere sister chromatid exchange. Hum Mol Genet (2009) 0.87
Telomere length in inherited bone marrow failure syndromes. Haematologica (2014) 0.85
Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010. Biol Blood Marrow Transplant (2010) 0.83
Aplastica anemia and viral hepatitis. Mediterr J Hematol Infect Dis (2009) 0.81
Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia. Haematologica (2014) 0.80
Dysfunctional telomeres in primary cells from Fanconi anemia FANCD2 patients. Genome Integr (2012) 0.80
Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia. Haematologica (2015) 0.79
Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Res (2011) 0.79
Abnormal telomere shortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia. Haematologica (2011) 0.77
FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres. Proc Natl Acad Sci U S A (2017) 0.76
Anemia of Central Origin. Semin Hematol (2015) 0.76
Impaired Autophagy in Adult Bone Marrow CD34+ Cells of Patients with Aplastic Anemia: Possible Pathogenic Significance. PLoS One (2016) 0.76
Fanconi anemia proteins in telomere maintenance. DNA Repair (Amst) (2016) 0.76
Telomerase dysfunction and dyskeratosis congenita. Cytotechnology (2004) 0.76
Expression of Shelterin component POT1 is associated with decreased telomere length and immunity condition in humans with severe aplastic anemia. J Immunol Res (2014) 0.75
Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome Engineering. Mol Ther (2015) 0.75
Isolation and therapeutic potential of human haemopoietic stem cells. Cytotechnology (2003) 0.75
Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med (2001) 4.45
Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med (2001) 4.39
Growth of human umbilical-cord blood in longterm haemopoietic cultures. Lancet (1992) 3.54
Quantitative studies of blood and bone marrow neutrophils in normal mice. Am J Physiol (1968) 3.33
The predictability of corneal flap thickness and tissue laser ablation in laser in situ keratomileusis. Ophthalmology (2000) 2.48
Severe cardiovascular depression with remifentanil. Anesth Analg (2000) 2.34
A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr (1979) 2.32
Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29
Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss--a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina. Eur J Cardiothorac Surg (1994) 2.28
Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol (2003) 2.15
Abnormalities in the mechanical properties of red blood cells caused by Plasmodium falciparum. Blood (1989) 2.12
Propofol-fentanyl anaesthesia in cardiac surgery: a comparison in patients with good and impaired ventricular function. Anaesthesia (1993) 2.04
Retinal abnormalities in diseases of the blood. Br J Ophthalmol (1969) 1.94
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood (2000) 1.93
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (1979) 1.83
Neutrophil kinetics in acute infection. J Clin Invest (1967) 1.78
Differential sensitivity to cryopreservation of clonogenic progenitor cells and stromal precursors from leukemic and normal bone marrow. Stem Cells (1994) 1.57
The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood (1996) 1.52
Diamond-Blackfan anaemia in the U.K.: analysis of 80 cases from a 20-year birth cohort. Br J Haematol (1996) 1.51
Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplant (2005) 1.47
Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling. Oncogene (2012) 1.45
Aplastic anaemia and remoxipride. Lancet (1993) 1.43
Bone marrow transplantation for Fanconi anemia. Blood (1995) 1.42
Fatal aplastic anaemia after mesalazine. Lancet (1994) 1.42
Is aplastic anaemia a pre-leukaemic disorder? Br J Haematol (1991) 1.42
Long-term culture of aplastic anaemia bone marrow. Br J Haematol (1990) 1.42
Female clients in substance abuse treatment. Int J Addict (1986) 1.41
Liver function abnormality following treatment with antithymocyte globulin for aplastic anaemia. Bone Marrow Transplant (1997) 1.40
Pharmacologic properties of Moringa oleifera. 2: Screening for antispasmodic, antiinflammatory and diuretic activity. J Ethnopharmacol (1992) 1.38
Relapse of severe aplastic anaemia after influenza immunization. Br J Haematol (2002) 1.37
Cyclosporin A, methylprednisolone, and convulsions. Lancet (1982) 1.37
Breast cancer genome-wide association studies: there is strength in numbers. Oncogene (2011) 1.34
Stability of cyclosporin A in human serum. J Clin Pathol (1983) 1.34
Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant (1991) 1.23
Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet (1984) 1.22
Increased monocyte tissue factor expression in coronary disease. Br Heart J (1995) 1.19
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood (2000) 1.19
Acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria: studies on clonality. Blood (1991) 1.18
Selective sparing of enterochromaffin cells in graft versus host disease affecting the colonic mucosa. Histopathology (1985) 1.18
Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplant (1986) 1.17
Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue". Cancer Res (1970) 1.15
Recurrent Corynebacterium equi infection with lymphoma. Cancer (1973) 1.14
Fanconi anaemia--constitutional, familial aplastic anaemia. Baillieres Clin Haematol (1989) 1.14
The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth. Oncogene (2006) 1.13
TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. Br J Cancer (2008) 1.13
The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review. Cancer Res (1976) 1.13
Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Br J Haematol (1999) 1.13
Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. Br J Haematol (2001) 1.11
The effect of treatment with Campath-1H in patients with autoimmune cytopenias. Br J Haematol (2001) 1.11
Chronic T cell lymphocytosis: a review of 21 cases. Br J Haematol (1984) 1.10
Pregnancy associated aplastic anaemia: a report of five cases and review of current management. Br J Haematol (1989) 1.08
Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia. Lancet (1982) 1.08
Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood (1992) 1.07
Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A. Br J Haematol (1983) 1.07
4-Hydroperoxycyclophosphamide inhibits proliferation by human granulocyte-macrophage colony-forming cells (GM-CFC) but spares more primitive progenitor cells. Leuk Res (1985) 1.04
Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anemia. Transplantation (1982) 1.03
Adult acute lymphoblastic leukaemia presenting with bone marrow aplasia. Clin Lab Haematol (1986) 1.03
Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax (1984) 1.03
Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood (1997) 1.03
Temperature and pH govern the self-assembly of microtubules from unfertilized sea-urchin egg extracts. J Cell Sci (1987) 1.02
Impact of physical training and detraining on endothelium-dependent vasodilation in patients with recent acute myocardial infarction. Am Heart J (2004) 1.02
Neutrophilia-inducing activity in plasma of neutropenic human beings. Blood (1971) 1.02
Mechanisms of bone marrow progenitor cell apoptosis in aplastic anaemia and the effect of anti-thymocyte globulin: examination of the role of the Fas-Fas-L interaction. Br J Haematol (2000) 1.02
Factors influencing hematopoietic spleen colony formation in irradiated mice. 3. The effect of repetitive irradiation upon proliferative ability of colony-forming cells. J Exp Med (1967) 1.01
Factors influencing hematopoietic spleen colony formation in irradiated mice. II. The effect of foreign materials. J Exp Med (1967) 1.01
Sickle cell disease in North London. Br J Haematol (1987) 1.01
Human immune responses in vivo to protein (KLH) and polysaccharide (DNP-Ficoll) neoantigens: normal subjects compared with bone marrow transplant patients on cyclosporine. Clin Exp Immunol (1986) 1.01
Phase I studies with trimetrexate: clinical pharmacology, analytical methodology, and pharmacokinetics. Cancer Res (1987) 1.00
Improved therapeutic index of methotrexate with "leucovorin rescue". Cancer Res (1973) 0.99
Effects of strabismus surgery on corneal topography. J Pediatr Ophthalmol Strabismus (1997) 0.98
Reversal of neuromuscular block. Heart rate changes with slow injection of neostigmine and atropine mixtures. Anaesthesia (1984) 0.97
Increased apoptosis in aplastic anemia bone marrow progenitor cells: possible pathophysiologic significance. Exp Hematol (1995) 0.97
Transmission of malaria by bone marrow transplantation. Transplantation (1986) 0.97
The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected]. Br J Cancer (1991) 0.97
Factors influencing hematopoietic spleen colony formation in irradiated mice. VI. The different effects of foreign plasma, endotoxin, and bleeding on colony-forming cell kinetics. Radiat Res (1968) 0.97
Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor. Clin Cancer Res (1998) 0.96
Letter: Alpha-thalassemia in Britain. Br Med J (1973) 0.96
Osteoclast lineage commitment of bone marrow precursors through expression of membrane-bound TRANCE. Bone (2000) 0.96
Nephrotoxicity of cyclosporin A. Lancet (1981) 0.95
The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking. Br J Haematol (1997) 0.95
New molecular targets in bone metastases. Cancer Treat Rev (2010) 0.95
Histiocytic medullary reticulosis complicating chronic lymphocytic leukaemia: malignant or reactive? Scand J Haematol (1981) 0.95
Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptors. Eur J Clin Invest (1994) 0.95
Immunosuppression with cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anaemia: preliminary studies. Br J Haematol (1981) 0.94